Peptidomimetic-based antibody surrogate for HER2-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Peptidomimetic-based antibody surrogate for HER2

Published:2021-09 Issue:9 Volume:11 Page:2645-2654
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Zheng Mengmeng,Li Chunpu,Zhou Mi,Jia Ru,She Fengyu,Wei Lulu,Cheng Feng,Li Qi,Cai Jianfeng^ORCID,Wang Yan

Funder

National Natural Science Foundation of China

Shanghai Municipal Human Resources Development Program for Outstanding Leaders in Medical Disciplines

University of San Francisco

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference34 articles.

1. ERBB receptors and cancer: the complexity of targeted inhibitors;Hynes;Nat Rev Cancer,2005

2. Clinical and pathological characterization of HER2 mutations in human breast cancer: a systematic review of the literature;Petrelli;Breast Cancer Res Treat,2017

3. Amplification of a novel v-erbB-related gene in a human mammary carcinoma;King;Science,1985

4. ERBB receptors: from oncogene discovery to basic science to mechanism-based cancer therapeutics;Arteaga Carlos;Cancer Cell,2014

5. The distinctive nature of HER2-positive breast cancers;Burstein;N Engl J Med,2005

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A Multivalent DNA Nanoparticle/Peptide Hybrid Molecular Modality for the Modulation of Protein–Protein Interactions in the Tumor Microenvironment;Advanced NanoBiomed Research;2024-04-25

2. The global patent landscape of HER2-targeted biologics;Nature Biotechnology;2023-06

3. Application of the Nicoya OpenSPR to Studies of Biomolecular Binding: A Review of the Literature from 2016 to 2022;Sensors;2023-05-17

4. The discovery of cyclic γ-AApeptides as the promising ligands targeting EP2;Bioorganic & Medicinal Chemistry Letters;2023-05

5. An HR2-Mimicking Sulfonyl-γ-AApeptide Is a Potent Pan-coronavirus Fusion Inhibitor with Strong Blood–Brain Barrier Permeability, Long Half-Life, and Promising Oral Bioavailability;ACS Central Science;2023-04-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3